| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.86B | 15.46B | 14.08B | 12.84B | 12.25B | 13.52B |
| Gross Profit | 4.48B | 4.31B | 3.81B | 3.36B | 3.02B | 3.33B |
| EBITDA | 1.98B | 1.92B | 1.58B | 1.33B | 1.23B | 1.44B |
| Net Income | 1.27B | 1.21B | 979.15M | 841.42M | 784.94M | 898.59M |
Balance Sheet | ||||||
| Total Assets | 9.83B | 9.89B | 10.20B | 9.34B | 8.07B | 8.14B |
| Cash, Cash Equivalents and Short-Term Investments | 3.30B | 2.89B | 3.76B | 3.39B | 2.81B | 1.68B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 87.50M |
| Total Liabilities | 2.71B | 2.81B | 2.91B | 2.66B | 2.10B | 2.81B |
| Stockholders Equity | 7.12B | 7.07B | 7.29B | 6.68B | 5.97B | 5.33B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 890.13M | 772.86M | 890.69M | 1.61B | 164.34M |
| Operating Cash Flow | 0.00 | 1.03B | 804.96M | 1.02B | 1.78B | 187.39M |
| Investing Cash Flow | 0.00 | -202.56M | -71.41M | -99.65M | -241.01M | -6.27M |
| Financing Cash Flow | 0.00 | -1.70B | -364.96M | -336.13M | -410.06M | -481.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥32.00B | 21.13 | ― | 2.18% | 9.56% | 30.03% | |
76 Outperform | ¥27.04B | 16.07 | ― | 1.70% | 22.25% | 31.88% | |
73 Outperform | ¥47.78B | 14.97 | 17.50% | 2.88% | 5.62% | 3.81% | |
73 Outperform | ¥33.63B | 11.50 | ― | 2.22% | 9.57% | 315.38% | |
72 Outperform | ¥32.38B | 14.25 | ― | 2.45% | 19.04% | 30.67% | |
65 Neutral | ¥32.65B | 10.11 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |